Amesite Inc. Stock News

Amesite (NASDAQ: AMST ) stock is rocketing higher on Wednesday after the artificial intelligence ( AI ) company announced the launch of a beta version of its NurseMagic app. NurseMagic is a tool desig

DETROIT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets,

Let's take a look at some of the top AI stocks in August 2023. For the most part, the average investor is familiar with the major names in the sector, such as  Nvidia (NASDAQ: NVDA ) and Microsoft (N

Amesite's CEO Ann Marie Sastry Special Guest in ARK Invest's PodcastAn Intriguing Discussion About The Future of Education and AI's Role In ItDETROIT, July 7, 2023 -- InvestorsHub NewsWire -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for education, business, and government markets, announces today that Dr. Ann Marie Sastry participated as a special guest in an ARK Invest Podcast hosted by Cathie Wood of ARK Invest and...

DETROIT, May 09, 2023 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, a

DETROIT, March 09, 2023 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retenti

DETROIT, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retentio

The Dow Jones closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste

Gainers Cingulate Inc (NASDAQ: CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD. Akebia Therapeutics In

U.S. stocks traded slightly higher toward the end of trading following the release of Fed minutes. The Dow traded up 0.15% to 33,180.87 while the NASDAQ rose 0.49% to 11,548.73. The S&P 500 also rose

Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formula

U.S. stocks traded slightly higher midway through trading, with the Dow Jones gaining around 20 points on Wednesday. The Dow traded up 0.06% to 33,150.23 while the NASDAQ rose 0.09% to 11,502.15. The

U.S. stocks traded slightly higher this morning, with the Dow Jones gaining 0.1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.09% to 33,157.87 while the NASDAQ rose 0.32%

Amesite Inc. (NASDAQ: AMST) shares are trading lower by 3.89% to 33 cents during Tuesday's after-hours session. The company announced that it will effect a 1-for-12 reverse split of its common stock

DETROIT, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retentio